Asia Expansion The company has launched China-focused products such as YOUTHLY, Luna XT and PERLE, and has partnered to advance breast reconstruction tech in Asia. This signals a strong sales opportunity to grow through local distributors, regulatory support, and surgeon training in China and neighboring markets. Action: identify China/Asia distributors, plan localized marketing and training programs, and align regulatory timelines.

Strategic Partnerships Board changes and partnerships indicate a growth-oriented strategy and openness to channel expansion, creating opportunities for distributor agreements, co-marketing, and technology partnerships to accelerate market access. Action: target global distributors and hospital networks; propose co-branded marketing and joint R&D opportunities.

IP Landscape Recent patent infringement activity in the sector highlights a competitive IP environment around breast implants. Position as a risk-managed, IP-safe supplier with strong regulatory compliance and transparent post-market support. Action: conduct IP freedom-to-operate diligence, highlight safety/regulatory certifications, and develop differentiators tied to quality and compliance.

Digital Marketing Scale With Google Ads, Instagram, Analytics, and Dynamics in place, current revenue suggests room to scale. There is clear potential to grow lead generation and CRM-driven sales through region-targeted campaigns, surgeon-specific content, and partner referrals. Action: implement targeted campaigns in priority regions, build case studies, and optimize CRM workflows.

Portfolio Growth A broad implant and tissue expander portfolio with ongoing product launches supports cross-selling across procedures and geographies. Opportunity to position as a full-suite provider and grow average selling price through bundled offerings and surgeon training. Action: develop bundled offerings, regional marketing collateral, and training programs to drive adoption.